Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2008 Nov;111(2 Suppl):S87-91.
doi: 10.1016/j.ygyno.2008.07.052. Epub 2008 Oct 1.

Biologic therapeutics and molecular profiling to optimize wound healing

Marie N Menke  1 , Nathan B Menke, Cecelia H Boardman, Robert F Diegelmann
Affiliations
Review

Biologic therapeutics and molecular profiling to optimize wound healing

Marie N Menke et al. Gynecol Oncol. 2008 Nov.

Abstract

Non-healing wounds represent a significant cause of morbidity and mortality for a large portion of the adult population. Wounds that fail to heal are entrapped in a self-sustaining cycle of chronic inflammation leading to the destruction of the extracellular matrix. Among cancer patients, malnutrition, radiation, physical dehabilitation, chemotherapy, and the malignancy itself increase the likelihood of chronic wound formation, and these co-morbidity factors inhibit the normal wound healing process. Current wound treatments are aimed at some, but not all, of the underlying causes responsible for delayed healing of wounds. These impediments block the normal processes that allow normal progression through the specific stages of wound healing. This review summarizes the current information regarding the management and treatment of complex wounds that fail to heal normally and offers some insights into novel future therapies [Menke N, Ward KR, Diegelmann R. Non-healing wounds. Emerg Med Rep 2007; 28(4).,Menke NB, Ward KR, Witten TM, Bonchev DG, Diegelmann RF. Impaired wound healing. Clin Dermatol 2007;25:19-25].

PubMed Disclaimer

Conflict of interest statement

Conflict of interest statement

CHB has served on the Speakers’ Bureaus of GlaxoSmithKline and Merck. All other authors have no conflicts of interest to declare.

Figures

Figure 1
Figure 1
Comparison of the phases of normal wound healing with the appearance of specialized cells.
See this image and copyright information in PMC

References

    1. Menke N, Ward KR, Diegelmann R. Non-healing wounds. Emerg Med Rep. 2007;28(4)
    1. Menke NB, Ward KR, Witten TM, Bonchev DG, Diegelmann RF. Impaired wound healing. Clin Dermatol. 2007;25:19–25. - PubMed
    1. Lazarus GS, Cooper DM, Knighton DR, Margolis DJ, Pecoraro RE, Rodeheaver G, Robson MC. Definitions and guidelines for assessment of wounds and evaluation of healing. Arch Dermatol. 1994;130:489–493. - PubMed
    1. Mustoe TA, O'Shaughnessy K, Kloeters O. Chronic wound pathogenesis and current treatment strategies: a unifying hypothesis. Plast Reconstr Surg. 2006;117(7 Suppl):35S–41S. - PubMed
    1. Yager DR, Zhang LY, Liang HX, Diegelmann RF, Cohen IK. Wound fluids from human pressure ulcers contain elevated matrix metalloproteinase levels and activity compared to surgical wound fluids. J Invest Dermatol. 1996;107:743–748. - PubMed

Publication types